Skip to content
Send us your idea
Contact us
  • Home
  • Innovation Day
    • Innovation Day Event
    • Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Team
    • Partners
Menu
  • Home
  • Innovation Day
    • Innovation Day Event
    • Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Team
    • Partners
  • Home
  • Innovation Day
    • Innovation Day Event
    • Innovation Day Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Partners
    • Team
  • Send us your idea
  • Contact
Menu
  • Home
  • Innovation Day
    • Innovation Day Event
    • Innovation Day Application Page
  • Investment
    • How it works
    • Financing
    • Investment areas
  • News
  • Participations
  • About us
    • The Company
    • Partners
    • Team
  • Send us your idea
  • Contact
Back to overview

IMChip and MemoryLab Health granted NWO Take-Off Phase 1 and 2

Great news! Both IMChip and MemoryLab Health have been granted NWO Take-Off Grants, Phase 1 and 2 respectively – stimulating academic innovation and entrepreneurship within Dutch knowledge institutions.

IMChip

IMChip is on track to revolutionize the chip industry. The Groningen-based startup is building energy-efficient AI hardware by mimicking how the human brain works. Using memristors, they’re exploring brain-like signals to replace traditional, power-hungry computer models. After being awarded the MIT Feasibility grant before, the NWO Take-Off Phase 1 grant will accelerate the development of the innovative AI-chip, bringing it one step closer to market.

Find out more about IMChip

MemoryLab Health

MemoryLab Health tracks cognitive decline by analyzing how people perform on a short at-home test. Using computational phenotyping—mathematical models of how memory functions—they can diagnose mild cognitive impairment with the same accuracy as multi-day clinical evaluations. This makes early detection more accessible and less time-consuming. The Take-Off Phase 2 grant is set to support MemoryLab in its translation of fundamental scientific underpinnings to greater societal wellbeing.

Find out more about MemoryLab (Health)

 

 

 

Twitter
Facebook
LinkedIn
Email
WhatsApp
Back to overview

Start growing
your business with us

Send us your idea
Get in touch
  • Home
  • News
  • Participations
  • Contact
  • Investment
  • How it works
  • Financing
  • Investment areas
  • About us
  • Company
  • Partners
  • Team
Linkedin

Contact

  • Email us
  • +31 6 22 92 66 60

Address

  • Kadijk 4, 9747 AT Groningen
  • The Netherlands

RUG Ventures is a subsidiary company of

© Copyright 2021 – RUG Ventures